Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Interim guidance from HIVMA and AIDSinfo covers lab visits, opioid treatment programs, pregnant women and more.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Researchers used a harmless virus to deliver a gene for a broadly neutralizing HIV antibody to cells, which produced the antibody over time.
A recent NIH study found that adults have a much higher viral suppression rate than youth.
But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.
Researchers have been searching for agents that can wake HIV from its resting state in an effort to flush out the viral reservoir.
The American Cancer Society sets the record straight.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
That’s the focus of one of three federal grants to research and address the island’s epidemic.
Last year, the federal agency invested nearly $300 million in the search for HIV cure therapies.
Over $12 million in grants has been awarded to the Wistar Institute to research the links between opioid receptors and immune activation.
Recently, ViiV Healthcare applied for approval of the first long-acting injectable HIV regimen.
This $14 million research project aims to find out. Here’s why it’s based in Miami.
The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.
Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.